INO-9012

INO-9012 · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INO-9012, covering 2025-07-10 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC [Phase 1, Phase 2]

See pricing